Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACHIEVE: Antihypertensive Therapy in Preeclampsia
NCT05676476Recruiting
- Sponsor
- University of Alabama at Birmingham
- Start
- Feb 2023
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Randomised, open-label trial in preeclampsia and gestational hypertension (GH) (2 arms), sponsored by University of Alabama at Birmingham. Primary endpoint: Mean number of days from randomization to delivery at 14 weeks. Started Feb 2023; status: recruiting.
02
Conditions
preeclampsiagestational hypertension (GH)
Beyond the preview
Go deeper on NCT05676476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05676476.